Yubo International Biotech Limited (YBGJ)

OTCMKTS · Delayed Price · Currency is USD
0.0100
0.00 (0.00%)
Apr 21, 2026, 9:30 AM EST
Market Cap1.70M -97.2%
Revenue (ttm)12.35K +256.0%
Net Income-1.08M
EPS-0.01
Shares Out170.42M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Average Volume44,162
Open0.0100
Previous Close0.0100
Day's Range0.0100 - 0.0100
52-Week Range0.0079 - 0.1776
Beta0.71
RSI38.72
Earnings DateMay 14, 2026

About YBGJ

Yubo International Biotech Limited, through its subsidiaries, focuses on the research, development, and application of endometrial stem cells. The company offers healthcare products for respiratory system, skincare products, hair care products, healthy beverages, and male and female personal care products; and stem cell related services, including cell testing and health management consulting services under the VIVCELL brand. Yubo International Biotech Limited is headquartered in Beijing, China. [Read more]

Sector Healthcare
CEO Yang Wang
Employees 14
Stock Exchange OTCMKTS
Ticker Symbol YBGJ
Full Company Profile

Financial Performance

In 2025, YBGJ's revenue was $12,353, an increase of 255.99% compared to the previous year's $3,470. Losses were -$1.08 million, -39.21% less than in 2024.

Financial Statements